Nomura Holdings’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,346
Closed -$395K 1752
2024
Q4
$395K Buy
+4,346
New +$399K ﹤0.01% 1878
2024
Q3
Sell
-7,111
Closed -$653K 1521
2024
Q2
$653K Sell
7,111
-35,212
-83% -$3.27M ﹤0.01% 1252
2024
Q1
$3.9M Sell
42,323
-6,974
-14% -$654K 0.01% 712
2023
Q4
$4.69M Buy
49,297
+42,297
+604% +$3.95M 0.01% 680
2023
Q3
$654K Buy
7,000
+1,000
+17% +$92.4K ﹤0.01% 1077
2023
Q2
$549K Buy
+6,000
New +$492K ﹤0.01% 1036
2021
Q4
Sell
-2,100
Closed -$304K 2222
2021
Q3
$304K Buy
+2,100
New +$437K ﹤0.01% 1564
2021
Q2
Sell
-3,418
Closed -$908K 1996
2021
Q1
$908K Buy
+3,418
New +$964K ﹤0.01% 1131
2015
Q4
Sell
-9,200
Closed -$353K 1832
2015
Q3
$353K Sell
9,200
-3,692
-29% -$156K ﹤0.01% 1107
2015
Q2
$513K Buy
12,892
+1,819
+16% +$56.7K ﹤0.01% 1252
2015
Q1
$296K Buy
+11,073
New +$312K ﹤0.01% 1339
2013
Q3
Sell
-83,628
Closed -$971K 2316
2013
Q2
$971K Buy
+83,628
New +$958K 0.01% 995

Other funds holding AMED

Nomura Holdings's AMED Position: Q1 2025 in Review

Nomura Holdings sold out of Amedisys (AMED) in Q1 2025, closing a stake of 4,346 shares — an estimated $395K sold.

Nomura Holdings first reported a position in AMED in Q2 2013 and held it in 12 quarters. The position peaked at $4.69M in Q4 2023. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Nomura Holdings reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • Nomura Holdings sold 4,346 Amedisys shares in Q1 2025, an estimated $395K.
  • Nomura Holdings first reported a position in Amedisys in Q2 2013 and held it in 12 quarters.
  • Nomura Holdings's Amedisys position peaked at $4.69M in Q4 2023.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Nomura Holdings's 13F filing for Q1 2025, filed 15 May 2025.